Skip to main content

Advertisement

Log in

Poor Adherence to National Clinical Management Guidelines: A Population-Based, Cross-Sectional Study of the Surgical Management of Melanoma in New South Wales, Australia

  • Melanomas
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Standardization of the clinical management of melanoma through the formulation of national guidelines, based on interpretation of the existing evidence and consensus expert opinion, seeks to improve quality of care; however, adherence to national guidelines has not been well studied.

Methods

A population-based, cross-sectional study of the clinical management of all patients with newly notified primary melanomas in the state of New South Wales, Australia, during 2006/2007 was conducted using cancer registry identification and questionnaires completed by treating physicians.

Results

Surgical margin guidelines were adhered to in 35% of cases; 45% were over treated and 21% were undertreated. Factors independently associated with non-concordance on multivariate analysis were lower Breslow thickness, lower socio-economic status of the physician’s practice location, older physician age, lower physician caseload, and physicians who biopsied the lesion and then referred for definitive management. Complications were not related to over- or under-treatment on multivariate analysis (p = 0.72). Sentinel lymph node biopsy was performed in 17% of patients with invasive melanoma, with the main determinant for selection being a Breslow thickness >0.75 mm.

Conclusions

The low level of concordance with national guidelines for surgical management of melanoma resulted in overtreatment of many patients. However, a fifth of patients were undertreated, which is likely to have resulted in increased locoregional recurrence rates. The better concordance achieved by physicians treating >30 melanomas per year suggests that a minimum caseload threshold for physicians treating melanoma patients would be desirable. High guideline concordance will ensure patients receive optimal care and minimize morbidity and health service costs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. World Health Organization. Ultraviolet radiation and the INTERSUN Programme. 2015. http://www.who.int/uv/faq/skincancer/en/index1.html. Accessed 5 May 2015.

  2. Australian Institute of Health and Welfare. Cancer in Australia: an overview 2012 (online version). 2015. http://www.aihw.gov.au/cancer/cancer-in-australia-overview-2012/data-at-a-glance/. Accessed 5 May 2015.

  3. Cancer Research UK. Cancer incidence for common cancers. 2015. http://www.cancerresearchuk.org/cancer-info/cancerstats/incidence/commoncancers/#Twenty.

  4. National Health and Medical Research Council. Clinical practice guidelines for the management of melanoma in Australia and New Zealand. 2008. https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/cp111.pdf. Accessed 6 May 2015.

  5. Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, et al. Malignant melanoma S3-guideline “diagnosis, therapy and follow-up of melanoma”. J Dtsch Dermatol Gas. 2013;11:1–116.

    Google Scholar 

  6. Mangas C, Paradelo C, Puig S, Gallardo F, Marcoval J, Azon A, et al. Initial evaluation, diagnosis, staging, treatment, and follow-up of patients with primary cutaneous malignant melanoma. Consensus statement of the Network of Catalan and Balearic Melanoma Centers [in Spanish]. Acta Dermosifiliogr. 2010;101:129–42.

    Article  CAS  Google Scholar 

  7. Marsden JR, Newton-Bishop JA, Burrows L, Cook M, Corrie PG, Cox NH, et al. Revised UK guidelines for the management of cutaneous melanoma 2010. J Plast Reconstr Aesthet Surg. 2010;63:1401–19.

    Article  CAS  PubMed  Google Scholar 

  8. National Health and Medical Research Council. Clinical practice guidelines for the management of melanoma. 1999. https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/cp68.pdf. Accessed 7 May 2015.

  9. Livingstone E, Windemuth-Kieselbach C, Eigentler TK, Rompel R, Trefzer U, Nashan D, et al. A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up. Eur J Cancer. 2011;47:1977–89.

    Article  PubMed  Google Scholar 

  10. Silverman MK, Golomb FM, Kopf AW, Grin-Jorgensen CM, Vossaert KA, Doyle JP, et al. Verification of a formula for determination of preexcision surgical margins from fixed-tissue melanoma specimens. J Am Acad Dermatol. 1992;27:214–19.

    Article  CAS  PubMed  Google Scholar 

  11. Deddens JA, Petersen MR. RE: Estimating the relative risk in cohort studies and clinical trials of common outcome [letter]. Am J Epidemiol. 2004;159(2):213.

    Article  PubMed  Google Scholar 

  12. Pink B. Socio-Economic Indexes for Areas (SEIFA). Canberra, ACT: Australian Bureau of Statistics; 2011.

    Google Scholar 

  13. Australian Institute of Health and Welfare. Rural and remote health: a guide to remoteness classifications. Canberra, ACT: Australian Institute of Health and Welfare; 2004.

    Google Scholar 

  14. Information and Research Branch, Department of Health and Aged Care. Measuring remoteness: Accessibility/Remoteness Index of Australia (ARIA). Canberra, ACT: Commonwealth of Australia; 2001.

  15. McKinnon JG, Starritt EC, Scolyer RA, McCarthy WH, Thompson JF. Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas ≤2 mm Thick. Ann Surg. 2005;241:326–33.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Wheatley K, Wilson JS, Gaunt P, Marsden JR. Surgical excision margins in primary cutaneous melanoma: a meta-analysis and Bayesian probability evaluation. Cancer Treat Rev. 2016;42:73–81.

    Article  PubMed  Google Scholar 

  17. O’Rourke MG, Bourke C. Recommended width of excision for primary malignant melanoma. World J Surg. 1995;19:343–45.

    Article  PubMed  Google Scholar 

  18. Morton DL, Cochran AJ, Thompson JF, Elashoff R, Essner R, Glass EC, et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005;242:302–11.

    PubMed  PubMed Central  Google Scholar 

  19. Erickson Foster J, Velasco JM, Hieken TJ. Adverse outcomes associated with noncompliance with melanoma treatment guidelines. Ann Surg Oncol. 2008;15:2395–02.

    Article  PubMed  Google Scholar 

Download references

Funding

This study was funded by the Cancer Institute NSW, with additional financial support provided by Melanoma Institute Australia and the NSW Melanoma Network. Anne E. Cust was supported by an NHMRC Career Development Fellowship (No. 1063593) and a Cancer Institute NSW Fellowship (No. 15/CDF/1-14). Richard A. Scolyer is supported by an NHMRC Practitioner Fellowship. John F. Thompson is supported by the Medical Foundation of the University of Sydney.

Disclosures

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John F. Thompson MD, FRACS, FACS.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 70 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Varey, A.H.R., Madronio, C.M., Cust, A.E. et al. Poor Adherence to National Clinical Management Guidelines: A Population-Based, Cross-Sectional Study of the Surgical Management of Melanoma in New South Wales, Australia. Ann Surg Oncol 24, 2080–2088 (2017). https://doi.org/10.1245/s10434-017-5890-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-017-5890-7

Keywords

Navigation